CANY
XRAY icon

Caxton Associates (New York)’s Dentsply Sirona XRAY Stock Holding History

Caxton Associates (New York)’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,792
Closed -$1.05M – 696
2024
Q3 		$1.05M Buy
+38,792
New +$991K 0.04% 234
2023
Q1 		– Sell
-45,866
Closed -$1.46M – 662
2022
Q4 		$1.46M Sell
45,866
-8,194
-15% -$247K 0.1% 74
2022
Q3 		$1.53M Buy
54,060
+31,569
+140% +$1.08M 0.2% 49
2022
Q2 		$804K Buy
+22,491
New +$910K 0.08% 170

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Associates (New York)'s XRAY Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Dentsply Sirona (XRAY) in Q4 2024, closing a stake of 38,792 shares — an estimated $1.05M sold.

Caxton Associates (New York) first reported a position in XRAY in Q2 2022 and held it in 4 quarters. The position peaked at $1.53M in Q3 2022. 359 funds tracked by Wall St. Rank hold XRAY as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Dentsply Sirona position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 38,792 Dentsply Sirona shares in Q4 2024, an estimated $1.05M.
  • Caxton Associates (New York) first reported a position in Dentsply Sirona in Q2 2022 and held it in 4 quarters.
  • Caxton Associates (New York)'s Dentsply Sirona position peaked at $1.53M in Q3 2022.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.